We are live on ! Find out more
SKBI

SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI

Delisted

SKBI was delisted on the 18th of December, 2015.

Back to rankings

4 hedge funds and large institutions have $351K invested in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in 2013 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Corsair Capital Management
New York
$308K +$341K +240,794 New
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$19K +$22.5K +15,900 New
Mitsubishi UFJ Asset Management
3
Mitsubishi UFJ Asset Management
Japan
$18K +$21.2K +15,000 New
U
4
UBS
Switzerland
$6K +$6.24K +4,405 New

SKBI Hedge Fund Activity: Q2 2013 in Review

4 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) for Q2 2013, worth a combined $351K.

Buyers outnumbered sellers: 4 funds opened new SKBI positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $351K of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) stock for Q2 2013.
  • 4 funds opened new SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) positions in Q2 2013 and 0 closed out, a net change of +4 holders.

Based on aggregated 13F filings for Q2 2013.